Details for New Drug Application (NDA): 205388
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 205388 describes OMIDRIA, which is a drug marketed by Rayner Surgical and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug and one Paragraph IV challenge. Additional details are available on the OMIDRIA profile page.
The generic ingredient in OMIDRIA is ketorolac tromethamine; phenylephrine hydrochloride. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ketorolac tromethamine; phenylephrine hydrochloride profile page.
The generic ingredient in OMIDRIA is ketorolac tromethamine; phenylephrine hydrochloride. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ketorolac tromethamine; phenylephrine hydrochloride profile page.
Summary for 205388
| Tradename: | OMIDRIA |
| Applicant: | Rayner Surgical |
| Ingredient: | ketorolac tromethamine; phenylephrine hydrochloride |
| Patents: | 7 |
Pharmacology for NDA: 205388
| Mechanism of Action | Adrenergic alpha1-Agonists Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 205388
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OMIDRIA | ketorolac tromethamine; phenylephrine hydrochloride | SOLUTION;IRRIGATION | 205388 | NDA | Omeros Corporation | 62225-600 | 62225-600-00 | 1 VIAL in 1 CARTON (62225-600-00) / 4 mL in 1 VIAL |
| OMIDRIA | ketorolac tromethamine; phenylephrine hydrochloride | SOLUTION;IRRIGATION | 205388 | NDA | Omeros Corporation | 62225-600 | 62225-600-04 | 4 VIAL in 1 CARTON (62225-600-04) / 4 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;IRRIGATION | Strength | EQ 0.3% BASE;EQ 1% BASE | ||||
| Approval Date: | May 30, 2014 | TE: | AT | RLD: | Yes | ||||
| Patent: | See Plans and Pricing | Patent Expiration: | Jan 30, 2024 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
| Patent: | See Plans and Pricing | Patent Expiration: | Jan 30, 2024 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
| Patent: | See Plans and Pricing | Patent Expiration: | Apr 23, 2034 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Complete Access Available with Subscription
